Orexigen Therapeutic (OREX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OREX | AZN | AMGN | GILD | BMY |
| Company | Orexigen Therapeutic | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.25 | 199.78 | 352.72 | 139.61 | 60.23 |
| High | 0.32 | 204.34 | 354.16 | 141.34 | 60.58 |
| Low | 0.22 | 199.23 | 345.87 | 138.64 | 59.10 |
| Latest | 0.22 | 202.39 | 346.88 | 139.10 | 59.40 |
| Change | -0.12 | +1.66 | -6.40 | -1.20 | -1.70 |
| % Change | -34.41% | +0.83% | -1.81% | -0.86% | -2.78% |
| Volume | 3,735,400 | 1,379,282 | 680,969 | 1,992,947 | 6,359,243 |
| 20-Day Average Volume | 2,308,280 | 1,801,700 | 2,622,686 | 5,994,629 | 13,318,927 |
| Previous Close | 0.34 | 200.73 | 353.28 | 140.30 | 61.10 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.47 | 191.35 | 358.22 | 141.23 | 59.30 |
| 20-Day Raw Stochastic | 4.24% | 90.38% | 3.38% | 34.15% | 48.31% |
| 20-Day Relative Strength | 32.36 | 59.10 | 42.23 | 47.12 | 50.65 |
| Weighted Alpha | -72.99 | +48.68 | +18.93 | +30.79 | +16.67 |
| Today's Opinion | N/A | 88% Buy | 24% Buy | 40% Buy | 88% Buy |
| Previous Opinion | N/A | 80% Buy | 40% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | N/A | 88% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.37% since 03/27/18 | +10.26% since 03/26/26 | -1.99% since 03/26/26 | +1.68% since 03/26/26 | -0.32% since 03/26/26 |
| Low | 0.17 on 03/28/18 | 187.95 on 03/27/26 | 345.87 on 04/02/26 | 133.89 on 03/30/26 | 58.37 on 03/27/26 |
| High | 0.39 on 04/02/18 | 204.32 on 04/02/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | -81.57% since 03/02/18 | -0.75% since 03/02/26 | -10.26% since 03/02/26 | -7.23% since 03/02/26 | -4.97% since 03/02/26 |
| Low | 0.17 on 03/27/18 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 1.42 on 03/09/18 | 204.32 on 04/02/26 | 381.74 on 03/03/26 | 149.38 on 03/10/26 | 62.58 on 03/04/26 |
| 3-Month | |||||
| %Chg | -82.02% since 01/03/18 | +10.41% since 01/02/26 | +5.65% since 01/02/26 | +14.46% since 01/02/26 | +10.81% since 01/02/26 |
| Low | 0.17 on 03/27/18 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 1.60 on 02/22/18 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -89.17% since 10/03/17 | +20.87% since 10/02/25 | +16.39% since 10/02/25 | +25.89% since 10/02/25 | +29.54% since 10/02/25 |
| Low | 0.17 on 03/27/18 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 109.66 on 10/03/25 | 42.52 on 10/29/25 |
| High | 2.32 on 10/13/17 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,212 | 311,313,728 | 190,441,936 | 174,143,456 | 126,036,304 |
| Shares Outstanding, K | 18,890 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 33,710,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -24,520,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 18,900,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -20,830,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 2.46 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.35 on 11/13/17 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/08/18 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.53 | 16.10 | 17.10 | 9.86 |